124 related articles for article (PubMed ID: 38930418)
1. The Probiotic Strain
Bouasker S; Nodland S; Millette M
Microorganisms; 2024 May; 12(6):. PubMed ID: 38930418
[No Abstract] [Full Text] [Related]
2. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection.
Auclair J; Frappier M; Millette M
Clin Infect Dis; 2015 May; 60 Suppl 2():S135-43. PubMed ID: 25922399
[TBL] [Abstract][Full Text] [Related]
4. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
Maziade PJ; Pereira P; Goldstein EJ
Clin Infect Dis; 2015 May; 60 Suppl 2():S144-7. PubMed ID: 25922400
[TBL] [Abstract][Full Text] [Related]
5. Probiotics and prevention of Clostridium difficile infection.
Goldstein EJC; Johnson SJ; Maziade PJ; Evans CT; Sniffen JC; Millette M; McFarland LV
Anaerobe; 2017 Jun; 45():114-119. PubMed ID: 27988389
[TBL] [Abstract][Full Text] [Related]
6. The synergistic effect of cell wall extracted from probiotic biomass containing Lactobacillus acidophilus CL1285, L. casei LBC80R, and L. rhamnosus CLR2 on the anticancer activity of cranberry juice-HPLC fractions.
Desrouillères K; Millette M; Bagheri L; Maherani B; Jamshidian M; Lacroix M
J Food Biochem; 2020 May; 44(5):e13195. PubMed ID: 32185816
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
Preston K; Krumian R; Hattner J; de Montigny D; Stewart M; Gaddam S
Benef Microbes; 2018 Sep; 9(5):697-706. PubMed ID: 29888656
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
McFarland LV; Ship N; Auclair J; Millette M
J Hosp Infect; 2018 Aug; 99(4):443-452. PubMed ID: 29702133
[TBL] [Abstract][Full Text] [Related]
9. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients.
Gao XW; Mubasher M; Fang CY; Reifer C; Miller LE
Am J Gastroenterol; 2010 Jul; 105(7):1636-41. PubMed ID: 20145608
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans.
Grompone G; Martorell P; Llopis S; González N; Genovés S; Mulet AP; Fernández-Calero T; Tiscornia I; Bollati-Fogolín M; Chambaud I; Foligné B; Montserrat A; Ramón D
PLoS One; 2012; 7(12):e52493. PubMed ID: 23300685
[TBL] [Abstract][Full Text] [Related]
11. Caenorhabditis elegans immune conditioning with the probiotic bacterium Lactobacillus acidophilus strain NCFM enhances gram-positive immune responses.
Kim Y; Mylonakis E
Infect Immun; 2012 Jul; 80(7):2500-8. PubMed ID: 22585961
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus paracasei subsp. paracasei 2004 improves health and lifespan in Caenorhabditis elegans.
Kishimoto S; Nono M; Makizaki Y; Tanaka Y; Ohno H; Nishida E; Uno M
Sci Rep; 2024 May; 14(1):10453. PubMed ID: 38714725
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis of the Clostridioides difficile response to a specific lactobacilli probiotic formulation: explanations for its mechanisms of action.
Masset Z; Gunaratnam S; Millette M; McFarland LV; Lacroix M
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36898672
[TBL] [Abstract][Full Text] [Related]
14. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
McFarland LV; Evans CT; Goldstein EJC
Front Med (Lausanne); 2018; 5():124. PubMed ID: 29868585
[TBL] [Abstract][Full Text] [Related]
15. Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.
Aroutcheva A; Auclair J; Frappier M; Millette M; Lolans K; de Montigny D; Carrière S; Sokalski S; Trick WE; Weinstein RA
Probiotics Antimicrob Proteins; 2016 Mar; 8(1):31-40. PubMed ID: 26915093
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Regulation of Longevity and Immune Response in
Lee DJ; Eor JY; Kwak MJ; Lee J; Kang AN; Mun D; Choi H; Song M; Kim JN; Kim JM; Yang J; Kim HW; Oh S; Kim Y
J Microbiol Biotechnol; 2024 May; 34(5):1109-1118. PubMed ID: 38563104
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus paracasei HII01 enhances lifespan and promotes neuroprotection in Caenorhabditis elegans.
Kumaree KK; Prasanth MI; Sivamaruthi BS; Kesika P; Tencomnao T; Chaiyasut C; Prasansuklab A
Sci Rep; 2023 Oct; 13(1):16707. PubMed ID: 37794096
[TBL] [Abstract][Full Text] [Related]
18. Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.
Sniffen JC; McFarland LV; Evans CT; Goldstein EJC
PLoS One; 2018; 13(12):e0209205. PubMed ID: 30586435
[TBL] [Abstract][Full Text] [Related]
19. Hibiscus sabdariffa L. extract prolongs lifespan and protects against amyloid-β toxicity in Caenorhabditis elegans: involvement of the FoxO and Nrf2 orthologues DAF-16 and SKN-1.
Koch K; Weldle N; Baier S; Büchter C; Wätjen W
Eur J Nutr; 2020 Feb; 59(1):137-150. PubMed ID: 30710163
[TBL] [Abstract][Full Text] [Related]
20. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
Bresee LC; Lamont N; Ocampo W; Holroyd-Leduc J; Sabuda D; Leal J; Dalton B; Kaufman J; Missaghi B; Kim J; Larios OE; Henderson E; Raman M; Fletcher JR; Faris P; Kraft S; Shen Y; Louie T; Conly JM
BMC Health Serv Res; 2023 Dec; 23(1):1386. PubMed ID: 38082421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
